🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

7.0T Magnetic Resonance Imaging Study of Parkinson's Disease

Recruitingn/aAges 18 Years - 80 YearsAllChinese PLA General Hospital
NCT06449404 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This clinical trial study is conducted to detect the imaging characteristics of the patients with Parkinson's diseases (PD) by 7-Tesla (7T) magnetic resonance imaging (MRI).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * the patients with PD who was diagnosed by the experienced neurologist specializing in movement disorders Exclusion Criteria: * the patients with brain disorders such as cerebrovascular disease, brain tumors, epilepsy, other neurodegenerative disease; * psychiatric disorders with impaired cognitive function; * contraindications to MRI.
💊

What it tests

  • 7T-MRI scaning
📍

Where

1 site
Chinese PLA General Hospital
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy